High risk of progression for chronic major organ complications of sickle cell disease in adolescents and young adults: A long-term neonatal cohort study

Affiliations

• ¹ Pediatric Department, Sickle Cell Disease Referral Center, Centre Hospitalier Intercommunal de Créteil, Créteil, France.
• ² Sorbonne University, Paris, France.
• ³ Adult Department, Sickle Cell Disease Referral Center, Centre Hospitalier Intercommunal de Créteil, Créteil, France.
• ⁴ Internal Medicine Department, Sickle Cell Disease Referral Center, Groupe Hospitalo-Universitaire Henri Mondor, INSERM U955, IMRB, Paris XII University, Créteil, France.
• ⁵ Internal Medicine Department, Sickle Cell Disease Referral Center, hôpital européen Georges Pompidou, Paris, France.
• ⁶ Hematologic Department, Sickle Cell Disease Referral Center, hôpital Saint Louis, Paris, France.
• ⁷ Hematologic Department, Sickle Cell Disease Referral Center, hôpital Tenon, Paris, France.
• ⁸ Sickle Cell Unit Referral Center, Centre Hospitalier Universitaire de Guadeloupe, Pointe-à-Pitre, Guadeloupe, France.
• ⁹ Sickle Cell Unit Referral Center, Centre Hospitalier Universitaire de Martinique, Fort-de-France, Martinique, France.
• ¹⁰ Internal Medicine Department, Sickle Cell Disease Referral Center, Groupe Hospitalo-Universitaire Henri Mondor, Créteil, France.
• ¹¹ Genetics Department, Groupe Hospitalo-Universitaire Henri Mondor, INSERM U955, IMRB, Team 2, Paris XII University, Créteil, France.
• ¹² BIOSSEC Clinical Biostatistics, Paris, France.
• ¹³ APHP (Assistance Publique des Hôpitaux de Paris), Paris, France.
• ¹⁴ INSERM U955, IMRB, Paris XII University, Créteil, France.